JP Stock MarketDetailed Quotes

JCR Pharmaceuticals (4552)

Watchlist
  • 522
  • -14-2.61%
20min DelayMarket Closed May 15 15:30 JST
67.70BMarket Cap29.21P/E (Static)

JCR Pharmaceuticals (4552) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Mar 31, 2026
(Q1)Jun 30, 2025
(FY)Mar 31, 2025
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
(Q3)Dec 31, 2023
(Q2)Sep 30, 2023
(Q1)Jun 30, 2023
(FY)Mar 31, 2023
Total revenue
21.91%40.32B
5.21%8.57B
-22.86%33.07B
-24.64%8.15B
24.83%42.87B
9.15B
-15.02%9.45B
125.34%13.46B
12.51%10.81B
-32.77%34.34B
Cost of revenue
-10.58%10.13B
13.70%2.36B
-2.47%11.33B
-38.36%2.07B
30.77%11.62B
3.2B
23.22%2.54B
32.32%2.52B
14.66%3.36B
-15.06%8.89B
Gross profit
38.86%30.19B
2.31%6.21B
-30.44%21.74B
-18.44%6.07B
22.76%31.25B
5.96B
-23.73%6.9B
168.81%10.95B
11.59%7.45B
-37.33%25.46B
Operating expense
4.37%29.63B
7.07%6.82B
19.69%28.39B
18.39%6.37B
15.82%23.72B
6.23B
23.72%5.99B
25.72%6.11B
4.73%5.38B
-1.00%20.48B
Operating profit
108.36%556M
-104.73%-606M
-188.30%-6.65B
-114.33%-296M
51.37%7.53B
-277M
-78.35%911M
710.87%4.83B
34.51%2.07B
-75.04%4.98B
Net non-operating interest income (expenses)
-654.76%-317M
-7,100.00%-70M
-268.00%-42M
105.26%1M
327.27%25M
22M
122.22%2M
385.71%20M
-111.11%-19M
71.05%-11M
Non-operating interest income
-28.32%81M
-66.67%9M
1.80%113M
--27M
236.36%111M
--45M
733.33%25M
925.00%41M
--0
371.43%33M
Non-operating interest expense
156.77%398M
203.85%79M
80.23%155M
36.84%26M
95.45%86M
--23M
91.67%23M
90.91%21M
90.00%19M
-2.22%44M
Net investment income
559.26%744M
-101.55%-7M
-120.43%-162M
-9.05%452M
91.08%793M
411M
36.29%-302M
-31.75%187M
-10.45%497M
-28.32%415M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets
666M
0
10M
Income from associates and other participating interests
60.60%-184M
77.50%-45M
57.16%-467M
32.66%-200M
-15,471.43%-1.09B
-214M
-369M
-210M
-297M
-7M
Special income (charges)
98.05%1.73B
-106.22%-39M
4,455.00%871M
627M
-25.00%-20M
-2M
-550.00%-13M
44.44%-5M
0
98.55%-16M
Less:Impairment of capital assets
-34.55%125M
--38M
--191M
----
--0
----
----
----
----
----
Less:Other special charges
-74.20%-1.85B
100.16%1M
-5,410.00%-1.06B
---627M
25.00%20M
--2M
550.00%13M
----
----
-98.55%16M
Other non-operating income (expenses)
-2.78%35M
107.98%17M
620.00%36M
-1,738.46%-213M
-88.64%5M
-65M
625.00%21M
36M
13M
15.79%44M
Income before tax
150.27%3.22B
-303.52%-751M
-188.54%-6.41B
-83.67%369M
33.85%7.24B
-127M
-93.25%251M
1,029.25%4.86B
8.50%2.26B
-72.11%5.41B
Income tax
159.20%1.02B
-209.76%-180M
-200.64%-1.72B
-74.89%164M
5.05%1.71B
-492M
-69.51%339M
1,028.46%1.21B
-8.42%653M
-66.74%1.63B
Net income
147.01%2.21B
-379.41%-570M
-184.81%-4.7B
-87.31%204M
46.18%5.54B
364M
-103.37%-88M
1,029.52%3.65B
17.38%1.61B
-73.91%3.79B
Net income continuous operations
147.00%2.21B
-378.54%-571M
-184.81%-4.7B
-87.24%205M
46.21%5.54B
--365M
-103.37%-88M
1,029.52%3.65B
17.30%1.61B
-73.92%3.79B
Noncontrolling interests
-55.56%28M
125.00%63M
250.00%3M
100.00%28M
17M
300.00%4M
-35.71%9M
-2M
40.00%14M
Net income attributable to the company
145.77%2.18B
-383.58%-570M
-186.42%-4.76B
-87.52%201M
46.00%5.51B
347M
-103.57%-93M
997.29%3.64B
17.69%1.61B
-74.00%3.77B
Preferred stock dividends
Other under preferred stock dividend
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
145.77%2.18B
-383.58%-570M
-186.42%-4.76B
-87.52%201M
46.00%5.51B
347M
-103.57%-93M
997.29%3.64B
17.69%1.61B
-74.00%3.77B
Gross dividend payment
Basic earnings per share
146.50%17.87
-378.26%-4.48
-187.08%-38.43
-87.53%1.61
45.40%44.13
2.78
-103.58%-0.75
987.23%29.19
16.73%12.91
-74.12%30.35
Diluted earnings per share
146.50%17.87
-378.26%-4.48
-187.50%-38.43
-87.47%1.61
45.33%43.92
2.76
-103.59%-0.75
982.98%29.05
16.61%12.85
-74.13%30.22
Dividend per share
0.00%20
0
0.00%20
0
0.00%20
10
0
0.00%10
0
0.00%20
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(FY)Mar 31, 2026(Q1)Jun 30, 2025(FY)Mar 31, 2025(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024(Q3)Dec 31, 2023(Q2)Sep 30, 2023(Q1)Jun 30, 2023(FY)Mar 31, 2023
Total revenue 21.91%40.32B5.21%8.57B-22.86%33.07B-24.64%8.15B24.83%42.87B9.15B-15.02%9.45B125.34%13.46B12.51%10.81B-32.77%34.34B
Cost of revenue -10.58%10.13B13.70%2.36B-2.47%11.33B-38.36%2.07B30.77%11.62B3.2B23.22%2.54B32.32%2.52B14.66%3.36B-15.06%8.89B
Gross profit 38.86%30.19B2.31%6.21B-30.44%21.74B-18.44%6.07B22.76%31.25B5.96B-23.73%6.9B168.81%10.95B11.59%7.45B-37.33%25.46B
Operating expense 4.37%29.63B7.07%6.82B19.69%28.39B18.39%6.37B15.82%23.72B6.23B23.72%5.99B25.72%6.11B4.73%5.38B-1.00%20.48B
Operating profit 108.36%556M-104.73%-606M-188.30%-6.65B-114.33%-296M51.37%7.53B-277M-78.35%911M710.87%4.83B34.51%2.07B-75.04%4.98B
Net non-operating interest income (expenses) -654.76%-317M-7,100.00%-70M-268.00%-42M105.26%1M327.27%25M22M122.22%2M385.71%20M-111.11%-19M71.05%-11M
Non-operating interest income -28.32%81M-66.67%9M1.80%113M--27M236.36%111M--45M733.33%25M925.00%41M--0371.43%33M
Non-operating interest expense 156.77%398M203.85%79M80.23%155M36.84%26M95.45%86M--23M91.67%23M90.91%21M90.00%19M-2.22%44M
Net investment income 559.26%744M-101.55%-7M-120.43%-162M-9.05%452M91.08%793M411M36.29%-302M-31.75%187M-10.45%497M-28.32%415M
Gain(Loss) on financial instruments designated as cash flow hedges
Gain(Loss) on derecognition of available-for-sale financial assets 666M010M
Income from associates and other participating interests 60.60%-184M77.50%-45M57.16%-467M32.66%-200M-15,471.43%-1.09B-214M-369M-210M-297M-7M
Special income (charges) 98.05%1.73B-106.22%-39M4,455.00%871M627M-25.00%-20M-2M-550.00%-13M44.44%-5M098.55%-16M
Less:Impairment of capital assets -34.55%125M--38M--191M------0--------------------
Less:Other special charges -74.20%-1.85B100.16%1M-5,410.00%-1.06B---627M25.00%20M--2M550.00%13M---------98.55%16M
Other non-operating income (expenses) -2.78%35M107.98%17M620.00%36M-1,738.46%-213M-88.64%5M-65M625.00%21M36M13M15.79%44M
Income before tax 150.27%3.22B-303.52%-751M-188.54%-6.41B-83.67%369M33.85%7.24B-127M-93.25%251M1,029.25%4.86B8.50%2.26B-72.11%5.41B
Income tax 159.20%1.02B-209.76%-180M-200.64%-1.72B-74.89%164M5.05%1.71B-492M-69.51%339M1,028.46%1.21B-8.42%653M-66.74%1.63B
Net income 147.01%2.21B-379.41%-570M-184.81%-4.7B-87.31%204M46.18%5.54B364M-103.37%-88M1,029.52%3.65B17.38%1.61B-73.91%3.79B
Net income continuous operations 147.00%2.21B-378.54%-571M-184.81%-4.7B-87.24%205M46.21%5.54B--365M-103.37%-88M1,029.52%3.65B17.30%1.61B-73.92%3.79B
Noncontrolling interests -55.56%28M125.00%63M250.00%3M100.00%28M17M300.00%4M-35.71%9M-2M40.00%14M
Net income attributable to the company 145.77%2.18B-383.58%-570M-186.42%-4.76B-87.52%201M46.00%5.51B347M-103.57%-93M997.29%3.64B17.69%1.61B-74.00%3.77B
Preferred stock dividends
Other under preferred stock dividend 0000000000
Net income attributable to common stockholders 145.77%2.18B-383.58%-570M-186.42%-4.76B-87.52%201M46.00%5.51B347M-103.57%-93M997.29%3.64B17.69%1.61B-74.00%3.77B
Gross dividend payment
Basic earnings per share 146.50%17.87-378.26%-4.48-187.08%-38.43-87.53%1.6145.40%44.132.78-103.58%-0.75987.23%29.1916.73%12.91-74.12%30.35
Diluted earnings per share 146.50%17.87-378.26%-4.48-187.50%-38.43-87.47%1.6145.33%43.922.76-103.59%-0.75982.98%29.0516.61%12.85-74.13%30.22
Dividend per share 0.00%2000.00%2000.00%201000.00%1000.00%20
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More